Synthesis of metarrestin analogs services. POP: july 30, 2021 through july 29, 2022
Ended Purchase Order Awarded Last action
- Contract number
- 75N95021P00376
- Awardee
-
American Biochemicals Inc. UEI M8PXMXZ1G2E5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $90,075
Award facts
- Opportunity
-
- Synthesis of small molecules PNC disassemblers with reduced brain exposure Pre-Solicitation · 75N95021Q00218 · Posted Dec 11, 2020
- Synthesis of metarrestin analogs Solicitation · Posted Jun 9, 2021
- Contract value 100% obligated
- $90,075.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- College Station, TX 77840, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $90,075 |
About this award
This is a $90,075 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to American Biochemicals Inc. The contract is for the synthesis of approximately 50 analogs of the small molecule compound metarrestin, which is being developed as an anti-metastasis agent for pancreatic cancer. The goal is to reduce the brain exposure of the compounds while maintaining their activity. This contract was awarded under an unrestricted solicitation, not a small business set-aside. American Biochemicals Inc. is a minority-owned, self-certified small disadvantaged business that provides expertise in small molecule synthesis and optimization.
Quick answers
Who was awarded contract 75N95021P00376?
75N95021P00376 was awarded to American Biochemicals Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 30, 2021.
How much is contract 75N95021P00376 worth?
The government has obligated $90,075 on 75N95021P00376.
Which agency awarded contract 75N95021P00376?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00376, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021P00376 competed?
The extent of competition for 75N95021P00376 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award